如何在全球高端设备领域掌握话语权？“深圳智造”又传喜报

Core Viewpoint - The announcement of the seventh batch of national-level specialized and innovative "little giant" enterprises highlights Shenzhen's Bao'an District, which has set a record by adding 102 new companies, becoming the first administrative region in the country to exceed 100 such recognitions in a single batch [1] Group 1: Company Achievements - Peninsula Medical has received the NMPA Class III medical device registration for its self-developed radiofrequency skin treatment device, "Peninsula Counterclockwise," marking it as the first domestic "golden microneedle" device to achieve this certification [1][4] - The device has also obtained FDA 510(k) certification, making it the only domestic radiofrequency microneedle product globally to hold both NMPA and FDA certifications [4] Group 2: Industry Development - The high-end medical device industry in Shenzhen is a key focus of the "20+8" industrial cluster policy, characterized by its technology and capital intensity, requiring high synergy between the innovation chain and industrial chain [5] - Shenzhen's supportive ecosystem allows companies like Peninsula Medical to efficiently transition from research and clinical trials to large-scale production, with 232 technology patents, of which 85 are authorized [5] Group 3: Regional Advantages - Bao'an District is transforming from a traditional manufacturing area to an "intelligent manufacturing stronghold," providing a robust foundation for hard-tech companies [6] - The district's strong supply chain management, lean manufacturing experience, and skilled workforce facilitate the conversion of advanced research into high-quality end products [6] - Bao'an's government is enhancing its service model to support innovation, transitioning from broad administrative approvals to targeted, full-chain support for enterprises [6][7]